{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T23:17:03Z","timestamp":1740179823396,"version":"3.37.3"},"reference-count":19,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2018,2,5]],"date-time":"2018-02-05T00:00:00Z","timestamp":1517788800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropsychopharm Rep"],"published-print":{"date-parts":[[2018,3]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Introduction<\/jats:title><jats:p>Patients with dentatorubral\u2010pallidoluysian atrophy (<jats:styled-content style=\"fixed-case\">DRPLA<\/jats:styled-content>) sometimes elicit psychosis. First\u2010generation antipsychotic drugs have been reported to be effective in treating psychotic symptoms associated with the disease. However, little information is available on the benefits of second\u2010generation antipsychotic drugs (<jats:styled-content style=\"fixed-case\">SGA<\/jats:styled-content>s).<\/jats:p><\/jats:sec><jats:sec><jats:title>Case<\/jats:title><jats:p>We report on a 47\u2010year\u2010old man with <jats:styled-content style=\"fixed-case\">DRPLA<\/jats:styled-content> whose psychotic symptoms were effectively treated with quetiapine, one of the <jats:styled-content style=\"fixed-case\">SGA<\/jats:styled-content>s. He suffered from delusions, auditory hallucinations, and disorganized speech. Initially, other antipsychotic drugs were tried, but were withdrawn because of adverse effects before switching to quetiapine.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Our observations add to the notion that some of the <jats:styled-content style=\"fixed-case\">SGA<\/jats:styled-content>s are useful for ameliorating psychosis in <jats:styled-content style=\"fixed-case\">DRPLA<\/jats:styled-content>.<\/jats:p><\/jats:sec>","DOI":"10.1002\/npr2.12005","type":"journal-article","created":{"date-parts":[[2018,1,2]],"date-time":"2018-01-02T07:28:48Z","timestamp":1514878128000},"page":"44-46","source":"Crossref","is-referenced-by-count":1,"title":["Successful treatment of psychosis in dentatorubral\u2010pallidoluysian atrophy with quetiapine: A case report"],"prefix":"10.1002","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7022-2141","authenticated-orcid":false,"given":"Zui","family":"Narita","sequence":"first","affiliation":[{"name":"Department of Psychiatry National Center Hospital National Center of Neurology and Psychiatry Tokyo Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomiki","family":"Sumiyoshi","sequence":"additional","affiliation":[{"name":"Department of Clinical Epidemiology Translational Medical Center National Center of Neurology and Psychiatry Tokyo Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2018,2,5]]},"reference":[{"key":"e_1_2_6_2_1","first-page":"378","article-title":"Pathological accumulation of atrophin\u20101 in dentatorubralpallidoluysian atrophy","volume":"4","author":"Suzuki Y","year":"2011","journal-title":"Int J Clin Exp Pathol"},{"key":"e_1_2_6_3_1","first-page":"1135","article-title":"Geographical distribution of origins of DRPLA family in Japan, and prevalence of DRPLA in Niigata prefecture","volume":"32","author":"Inatsuki G","year":"1990","journal-title":"Seishin Igaku"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(94)90497-9"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410370407"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.32.8.798"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.38.7.1065"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1176\/jnp.13.2.258"},{"journal-title":"Clin Psychopharmacol Neurosci","article-title":"Successful treatment with olanzapine of psychosis in dentatorubral\u2010pallidoluysian atrophy: a case report","author":"Narita Z","key":"e_1_2_6_9_1"},{"key":"e_1_2_6_10_1","first-page":"121","article-title":"Epileptic seizures in dentatorubral\u2010pallidoluysian atrophy four cases with marked deterioration of clinical condition corresponding to the appearance of epileptic seizures","volume":"17","author":"Sato K","year":"1999","journal-title":"Epilepsia"},{"key":"e_1_2_6_11_1","first-page":"745","article-title":"Four cases of progressive myoclonus epilepsy with paranoid state","volume":"34","author":"Adachi N","year":"1992","journal-title":"Seishin Igaku"},{"key":"e_1_2_6_12_1","first-page":"871","article-title":"A family of dentatorubropallidoluysian atrophy (DRPLA) including two cases with schizophrenic symptoms","volume":"74","author":"Naito H","year":"1987","journal-title":"Folia Psychiatr Neurol Jpn"},{"key":"e_1_2_6_13_1","doi-asserted-by":"crossref","unstructured":"American Psychiatric Association editor. Diagnostic and statistical manual of mental disorders. 5th ed. Washington: American Psychiatric Association Publishing; 2013.","DOI":"10.1176\/appi.books.9780890425596"},{"key":"e_1_2_6_14_1","first-page":"679","article-title":"Clinical application of second generation antipsychotics to organic, including symptomatic, mental disorders\u2010possibility of second generation antipsychotics to adaptation expansion for delirium and\/or higher brain disorder","volume":"12","author":"Shoji Y","year":"2009","journal-title":"Rinsho Seishin Yakuri"},{"issue":"4","key":"e_1_2_6_15_1","first-page":"21","article-title":"Expected incidence of tardive dyskinesia associated with atypical antipsychotics","volume":"61","author":"Glazer WM","year":"2000","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.164.2.177"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0920-9964(98)00105-4"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.08m04132"},{"issue":"8","key":"e_1_2_6_19_1","first-page":"31","article-title":"Review of quetiapine side effects","volume":"61","author":"Garver DL","year":"2000","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_6_20_1","first-page":"1163","article-title":"Clinical pharmacology of atypical antipsychotics: an update","volume":"13","author":"Mauri MC","year":"2014","journal-title":"EXCLI J"}],"container-title":["Neuropsychopharmacology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fnpr2.12005","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/npr2.12005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,24]],"date-time":"2023-09-24T16:36:31Z","timestamp":1695573391000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/npr2.12005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,5]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["10.1002\/npr2.12005"],"URL":"https:\/\/doi.org\/10.1002\/npr2.12005","archive":["Portico"],"relation":{},"ISSN":["2574-173X","2574-173X"],"issn-type":[{"type":"print","value":"2574-173X"},{"type":"electronic","value":"2574-173X"}],"subject":[],"published":{"date-parts":[[2018,2,5]]}}}